The strand displacement amplification (SDA) market is predicted to skyrocket to a valuation of US$ 1.5 billion by 2023's end, according to Future Market Insights. And that's just the beginning - a 4.3% CAGR surge is expected to take the SDA market to a value pool of US$ 2.3 billion by 2033.
Data Points | Key Statistics |
---|---|
Expected Market Value in 2023 | US$ 1.5 billion |
Projected Market Value in 2033 | US$ 2.3 billion |
Growth Rate (2023 to 2033) | 4.3% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The strand displacement amplification (SDA) market is poised for significant growth in the coming years, driven by numerous factors.
The strand displacement amplification (SDA) market presents numerous opportunities for market players to grow and expand their businesses. Some of the notable opportunities in the SDA market are:
The North American strand displacement amplification market is currently experiencing a period of significant growth and expansion. The growth of the market is being driven by several factors, including increased demand for DNA-based diagnostics, the development of new applications for SDA technology, and the increasing popularity of next-generation sequencing.
A prominent driver boosting the growth of the North American self-directed assistance market is the rising need for customized healthcare. As more healthcare providers adopt personalized medicine approaches, they are seeking new technologies that can help them identify and target the specific genetic mutations that cause diseases. SDA is an ideal technology for this purpose, as it allows for the rapid and cost-effective amplification of DNA sequences.
Strand Displacement Amplification (SDA) allows in-vitro nucleic acid amplification using isothermal technique. Nucleic acids being the encoding information in all living forms, used in detecting hereditary diseases, cancers and pathogens. Isothermal strand displacement amplification is a method alternative to PCR-based nucleic acid amplification.
PCR requires separate thermocycling apparatus whereas, strand displacement amplification allows 10(10)-fold amplification of a target DNA sequence without the use of external apparatus, making it robust and cost effective. Strand displacement amplification was the first amplification technology to be coupled with real-time homogeneous fluorescence-based detection for detecting various clinical conditions.
Thus, strand displacement amplification technique overcomes disadvantages of PCR. Isothermal strand displacement polymerase reaction (ISDPR) an advanced form of strand displacement amplification, is being widely used having more detection platforms.
Increasing cases of infectious diseases is one of the major cause of deaths. Tuberculosis, syphilis, malaria, pneumonia are most prevalent diseases. These conditions keeping its prevalence in current scenario also due to poor or late diagnosis. The Rapid amplification technique like strand displacement amplification technique without the use of thermocycling process, the technique is being opted by most of the countries.
Strand displacement amplification technique provides more significant results compared to culturing in cases of bacteremia due to early detection of organisms, thus increasing the demand of strand displacement amplification technique.
Moreover smear based diagnosis where results can be missed due to low levels of bacteria, strand displacement amplification technique is useful in making the diagnosis more sensitive leading the growth of strand displacement amplification market. Strand displacement amplification technique is emerging in agriculture and forensic, helping in the wide spread use of strand displacement amplification technique.
The multiple strand displacement amplification technique is also being evaluated in various developed countries which can provide results more efficiently. The strand displacement amplification technique require sample preparation, also cannot amplify long nucleotide sequences making it less efficient there by hampering the growth of strand displacement amplification market.
The results by strand displacement amplification technique can sometimes show false positive results which can be the major reason which can decline the use of strand displacement amplification technique. Also lack of skilled professionals can majorly restrict the demand for Strand displacement amplification market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The market for tuberculosis diagnosis is highly valued making it most rapid diagnosis due to sensitive results, rising health awareness are the factors responsible to increase the growth of strand displacement amplification market over forecast period.
Based on end user the global strand displacement amplification market will be dominated by diagnostic laboratories over the coming year as nucleic acid amplification has many values in the healthcare sector. Also, strand displacement amplification technique is used by research laboratories, majorly in the forensic labs, lead the growth of strand displacement amplification market.
Globally the Strand displacement amplification market especially includes in North America, Europe and Asia-Pacific, South America, and Africa. North America holds the maximum share in Strand displacement amplification market globally.
Strand displacement amplification market will experience rapid growth during the forecast period in APAC. Due to emergence of new small players ultimately increasing the growth of Strand displacement amplification market in Middle East and Africa.
Some of the profiled key players in Strand displacement amplificationt market that are prevalent globally include New England Biolabs, Hopax Fine Chemicals, Nippon Genetics .Co .Ltd, G Biosciences, BioRad. Proteon Pharmaceuticals, usually deals with the manufacturing of polymerase enzyme manufacturing used in Strand displacement amplification market.
Global strand displacement amplification market is segmented based on application, end user and region
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis and Forecast 6.1. Application 6.2. End User 7. Global Market Analysis and Forecast, By Application 7.1. Tuberculosis 7.2. Hepatitis 7.3. Pneumonia 7.4. Malaria 7.5. Cancer 8. Global Market Analysis and Forecast, By End User 8.1. Research institutes 8.2. Hospitals 8.3. Diagnostic laboratories 9. Global Market Analysis and Forecast, By Region 9.1. North America 9.2. Latin America 9.3. Europe 9.4. Asia Pacific 9.5. Middle East & Africa 9.6. Oceania 9.7. The Middle East and Africa (MEA) 10. North America Sales Analysis and Forecast, by Key Segments and Countries 11. Latin America Sales Analysis and Forecast, by Key Segments and Countries 12. Europe Sales Analysis and Forecast, by Key Segments and Countries 13. Asia Pacific Sales Analysis and Forecast, by Key Segments and Countries 14. Middle East & Africa Sales Analysis and Forecast, by Key Segments and Countries 15. Oceania Sales Analysis and Forecast, by Key Segments and Countries 16. The Middle East and Africa (MEA) Sales Analysis and Forecast, by Key Segments and Countries 17. Sales Forecast by Application and End User for 30 Countries 18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 19. Company Profile 19.1. England Biolabs 19.2. Hopax Fine Chemicals 19.3. Nippon Genetics Co., Ltd 19.4. G Biosciences 19.5. BioRad
Explore Healthcare Insights
View Reports